{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:40:26Z","timestamp":1792190426262,"version":"4.4.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.pharma.2024.06.003","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T13:41:42Z","timestamp":1719582102000},"page":"251-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Nanosuspensions: Enhancing drug bioavailability through nanonization"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1796-0722","authenticated-orcid":false,"given":"Rohit","family":"Chavhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2024.06.003_bib0300","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.powtec.2015.10.051","article-title":"Spray drying of cefixime nanosuspension to form stabilized and fast dissolving powder","volume":"288","author":"Alaei","year":"2016","journal-title":"Powder Technol"},{"issue":"5","key":"10.1016\/j.pharma.2024.06.003_bib0305","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3109\/10717544.2013.779331","article-title":"Formulation and evaluation of mucoadhesive buccal films impregnated with carvedilol nanosuspension: a potential approach for delivery of drugs having high first-pass metabolism","volume":"20","author":"Rana","year":"2013","journal-title":"Drug Deliv"},{"key":"10.1016\/j.pharma.2024.06.003_bib0310","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.powtec.2016.09.004","article-title":"Design of experiment approach in development of febuxostat nanocrystal: application of Soluplus\u00ae as stabilizer","volume":"302","author":"Sharma","year":"2016","journal-title":"Powder Technol"},{"key":"10.1016\/j.pharma.2024.06.003_bib0315","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jddst.2019.01.018","article-title":"Exploration of nanocrystal technology for the preparation of lovastatin immediate and sustained release tablets","volume":"50","author":"Jing","year":"2019","journal-title":"J Drug Deliv Sci Technol"},{"issue":"5","key":"10.1016\/j.pharma.2024.06.003_bib0320","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3109\/03639045.2012.702347","article-title":"Factors influencing the release kinetics of drug nanocrystal-loaded pellet formulations","volume":"39","author":"M\u00f6schwitzer","year":"2012","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"10.1016\/j.pharma.2024.06.003_bib0325","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0378-5173(02)00040-6","article-title":"Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability","volume":"237","author":"M\u00fcller","year":"2002","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.pharma.2024.06.003_bib0330","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nano.2016.08.007","article-title":"Safety of nanosuspensions in drug delivery","volume":"13","author":"Wang","year":"2016","journal-title":"Nanomedicine"},{"issue":"5","key":"10.1016\/j.pharma.2024.06.003_bib0335","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000065608","article-title":"Enhanced ocular anti-inflammatory activity of ibuprofen carried by an Eudragit RS100 nanoparticle suspension","volume":"34","author":"Bucolo","year":"2002","journal-title":"Ophthalmic Res"},{"issue":"3","key":"10.1016\/j.pharma.2024.06.003_bib0340","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/pharmaceutics10030134","article-title":"Nanocrystals of poorly soluble drugs: drug bioavailability and physicochemical stability","volume":"10","author":"Gigliobianco","year":"2018","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.pharma.2024.06.003_bib0345","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/QAI.0000000000000365","article-title":"Pharmacokinetics, safety, and tolerability with repeat doses of GSK1265744 and rilpivirine (TMC278) long-acting nanosuspensions in healthy adults","volume":"67","author":"Spreen","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.pharma.2024.06.003_bib0350","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/10717544.2012.742939","article-title":"Development and characterization of glimepiride nanocrystal formulation and evaluation of its pharmacokinetic in rats","volume":"20","author":"Du","year":"2013","journal-title":"Drug Deliv"},{"issue":"1","key":"10.1016\/j.pharma.2024.06.003_bib0355","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jsps.2018.07.018","article-title":"Formulation and evaluation of docetaxel nanosuspensions: in-vitro evaluation and cytotoxicity","volume":"27","author":"Ibrahim","year":"2018","journal-title":"Saudi Pharm J"},{"issue":"1","key":"10.1016\/j.pharma.2024.06.003_bib0360","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/21691401.2014.944645","article-title":"Preparation of budesonide nanosuspensions for pulmonary delivery: characterization, in vitro release and in vivo lung distribution studies","volume":"44","author":"Zhang","year":"2014","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"2","key":"10.1016\/j.pharma.2024.06.003_bib0365","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/10717544.2010.520353","article-title":"Preparation and characterization of intravenously injectable curcumin nanosuspension","volume":"18","author":"Gao","year":"2010","journal-title":"Drug Deliv"},{"issue":"NA","key":"10.1016\/j.pharma.2024.06.003_bib0370","first-page":"79","article-title":"Biological evaluation of PEG modified nanosuspensions based on human serum albumin for tumor targeted delivery of paclitaxel","volume":"83","author":"Yin","year":"2015","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"10.1016\/j.pharma.2024.06.003_bib0375","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1517\/17425247.2016.1142524","article-title":"Solidification of nanosuspensions for the production of solid oral dosage forms and inhalable dry powders","volume":"13","author":"Malamatari","year":"2016","journal-title":"Expert Opin Drug Deliv"},{"issue":"5","key":"10.1016\/j.pharma.2024.06.003_bib0380","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejps.2004.12.010","article-title":"Amphiphilic amino acid copolymers as stabilizers for the preparation of nanocrystal dispersion","volume":"24","author":"Lee","year":"2005","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"10.1016\/j.pharma.2024.06.003_bib0385","doi-asserted-by":"crossref","first-page":"510","DOI":"10.18433\/J3SW2T","article-title":"Preparation and physicochemical characterization of Eudragit\u00ae RL100 nanosuspension with potential for ocular delivery of sulfacetamide","volume":"13","author":"Mandal","year":"2010","journal-title":"J Pharm Pharm Sci"},{"issue":"Supplement 1","key":"10.1016\/j.pharma.2024.06.003_bib0390","first-page":"7","article-title":"Polyethylenimine-mediated delivery of small interfering RNA targeting the epidermal growth factor receptor: a comparison of linear and branched polymer architecture [abstract]","volume":"56","author":"Hollins","year":"2004","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.pharma.2024.06.003_bib0395","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejpb.2016.04.001","article-title":"Development of fast dissolving oral films containing lercanidipine HCl nanoparticles in semicrystalline polymeric matrix for enhanced dissolution and ex vivo permeation","volume":"103","author":"Chonkar","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1016\/j.pharma.2024.06.003_bib0400","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijpharm.2011.04.034","article-title":"Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility","volume":"413","author":"Mou","year":"2011","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.pharma.2024.06.003_bib0405","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1208\/s12249-013-9995-4","article-title":"Influence of critical parameters of nanosuspension formulation on the permeability of a poorly soluble drug through the skin\u00a0\u2013\u00a0a case study","volume":"14","author":"Ghosh","year":"2013","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/j.pharma.2024.06.003_bib0410","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.biotechadv.2013.11.006","article-title":"Techniques for physicochemical characterization of nanomaterials","volume":"32","author":"Lin","year":"2013","journal-title":"Biotechnol Adv"},{"issue":"7","key":"10.1016\/j.pharma.2024.06.003_bib0415","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.addr.2007.05.003","article-title":"Nanosizing\u00a0\u2013\u00a0oral formulation development and biopharmaceutical evaluation","volume":"59","author":"Kesisoglou","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"10.1016\/j.pharma.2024.06.003_bib0420","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s11095-007-9445-7","article-title":"A novel solid-in-oil nanosuspension for transdermal delivery of diclofenac sodium","volume":"25","author":"Piao","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharma.2024.06.003_bib0425","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jconrel.2014.06.059","article-title":"Nano-amorphous spray dried powder to improve oral bioavailability of itraconazole","volume":"192","author":"Kumar","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.pharma.2024.06.003_bib0430","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jddst.2018.12.013","article-title":"Formulation and characterization of fast dissolving oral films containing buspirone hydrochloride nanoparticles using design of experiment","volume":"49","author":"Bharti","year":"2019","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.pharma.2024.06.003_bib0435","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijpharm.2018.09.069","article-title":"Enhanced dissolution of naproxen from pure-drug, crystalline nanoparticles: a case study formulated into spray-dried granules and compressed tablets","volume":"554","author":"Braig","year":"2018","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.pharma.2024.06.003_bib0440","article-title":"Pharmacokinetic and tissue distributions of naringenin and naringenin nanosuspension","volume":"12","author":"Rajamani","year":"2018","journal-title":"Asian J Pharm"},{"issue":"1","key":"10.1016\/j.pharma.2024.06.003_bib0445","first-page":"227","article-title":"Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology","volume":"354","author":"Teeranachaideekul","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2024.06.003_bib0450","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.2147\/DDDT.S177316","article-title":"Enhanced oral bioavailability of fluvastatin by using nanosuspensions containing cyclodextrin","volume":"12","author":"Jun","year":"2018","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"10.1016\/j.pharma.2024.06.003_bib0455","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s40199-018-00235-2","article-title":"Formation of nanosuspensions in bottom-up approach: theories and optimization","volume":"27","author":"Tehrani","year":"2019","journal-title":"Daru"},{"issue":"1","key":"10.1016\/j.pharma.2024.06.003_bib0460","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2006.01.008","article-title":"Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs","volume":"312","author":"Kocbek","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2024.06.003_bib0465","first-page":"3281","article-title":"Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy","volume":"7","author":"Wang","year":"2012","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"10.1016\/j.pharma.2024.06.003_bib0470","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ejpb.2011.07.005","article-title":"Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets","volume":"79","author":"Lai","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"issue":"5","key":"10.1016\/j.pharma.2024.06.003_bib0475","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1128\/AAC.01529-09","article-title":"Pharmacokinetics and disposition of rilpivirine (TMC278) nanosuspension as a long-acting injectable antiretroviral formulation","volume":"54","author":"Van\u2019T Klooster","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.pharma.2024.06.003_bib0480","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ejps.2010.04.006","article-title":"Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability","volume":"40","author":"Xia","year":"2010","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.pharma.2024.06.003_bib0485","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0378-5173(02)00196-5","article-title":"Stabilization of amorphous indomethacin by co-grinding in a ternary mixture","volume":"241","author":"Watanabe","year":"2002","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.pharma.2024.06.003_bib0490","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.addr.2007.04.005","article-title":"Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug","volume":"59","author":"Hanafy","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.pharma.2024.06.003_bib0495","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejpb.2005.09.005","article-title":"Spray coated pellets as carrier system for mucoadhesive drug nanocrystals","volume":"62","author":"M\u00f6schwitzer","year":"2005","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.pharma.2024.06.003_bib0500","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.powtec.2018.09.096","article-title":"Application of quality by design for optimization of spray drying process used in drying of Risperidone nanosuspension","volume":"342","author":"Nair","year":"2019","journal-title":"Powder Technol"},{"issue":"2-3","key":"10.1016\/j.pharma.2024.06.003_bib0505","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0169-409X(96)00474-7","article-title":"Amphotericin B encapsulated in polyethylene glycol-immunoliposomes for infectious diseases","volume":"24","author":"Kohno","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.pharma.2024.06.003_bib0510","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.biomaterials.2018.09.005","article-title":"Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease","volume":"185","author":"Date","year":"2018","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.pharma.2024.06.003_bib0515","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ejpb.2006.05.008","article-title":"Preparation and in vitro\/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base","volume":"64","author":"Hecq","year":"2006","journal-title":"Eur J Pharm Biopharm"},{"issue":"9","key":"10.1016\/j.pharma.2024.06.003_bib0520","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1021\/js970100b","article-title":"The role of P-glycoprotein and canalicular multispecific organic anion transporter in the hepatobiliary excretion of drugs","volume":"87","author":"Kusuhara","year":"1998","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.pharma.2024.06.003_bib0525","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0168-3659(00)00269-8","article-title":"Investigation of the role of macrophages on the cytotoxicity of doxorubicin and doxorubicin-loaded nanoparticles on M5076 cells in vitro","volume":"68","author":"Soma","year":"2000","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.pharma.2024.06.003_bib0530","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejps.2012.04.020","article-title":"Application of spray granulation for conversion of a nanosuspension into a dry powder form","volume":"47","author":"Bose","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.pharma.2024.06.003_bib0535","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/IJN.S184374","article-title":"Novel redispersible nanosuspensions stabilized by co-processed nanocrystalline cellulose-sodium carboxymethyl starch for enhancing dissolution and oral bioavailability of baicalin","volume":"14","author":"Xie","year":"2019","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.pharma.2024.06.003_bib0540","series-title":"Nanotechnology environmental health and safety","first-page":"3","article-title":"Learning from the past, preparing for the future","author":"Hull","year":"2018"},{"key":"10.1016\/j.pharma.2024.06.003_bib0545","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jconrel.2018.12.046","article-title":"Development of a mucoinert progesterone nanosuspension for safer and more effective prevention of preterm birth","volume":"295","author":"Hoang","year":"2018","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.pharma.2024.06.003_bib0550","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.nano.2009.10.004","article-title":"Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery","volume":"6","author":"Gupta","year":"2009","journal-title":"Nanomedicine"},{"issue":"12","key":"10.1016\/j.pharma.2024.06.003_bib0555","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1021\/ja02086a003","article-title":"The rate of solution of solid substances in their own solutions","volume":"19","author":"Noyes","year":"1897","journal-title":"J Am Chem Soc"},{"issue":"1","key":"10.1016\/j.pharma.2024.06.003_bib0560","first-page":"3119","article-title":"Formulating food protein-stabilized indomethacin nanosuspensions into pellets by fluid-bed coating technology: physical characterization, redispersibility, and dissolution","volume":"8","author":"He","year":"2013","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"10.1016\/j.pharma.2024.06.003_bib0565","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejpb.2012.05.016","article-title":"Transdermal delivery of the anti-rheumatic agent methotrexate using a solid-in-oil nanocarrier","volume":"82","author":"Yang","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.pharma.2024.06.003_bib0570","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.carbpol.2014.11.070","article-title":"Maltodextrin fast dissolving films for quercetin nanocrystal delivery. A feasibility study","volume":"121","author":"Lai","year":"2014","journal-title":"Carbohydr Polym"},{"issue":"2","key":"10.1016\/j.pharma.2024.06.003_bib0575","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1166\/jnn.2019.15925","article-title":"Efficient method for preparation of rutin nanosuspension using chitosan and sodium tripolyphosphate crosslinker","volume":"19","author":"Phan","year":"2019","journal-title":"J Nanosci Nanotechnol"},{"issue":"3","key":"10.1016\/j.pharma.2024.06.003_bib0580","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.ejpb.2013.07.015","article-title":"Spray granulation: importance of process parameters on in vitro and in vivo behavior of dried nanosuspensions","volume":"85","author":"Figueroa","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1016\/j.pharma.2024.06.003_bib0585","first-page":"142","article-title":"Identifying the correlation between drug\/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology","volume":"48","author":"George","year":"2012","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.pharma.2024.06.003_bib0590","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijpharm.2013.10.007","article-title":"Nanosuspension improves tretinoin photostability and delivery to the skin","volume":"458","author":"Lai","year":"2013","journal-title":"Int J Pharm"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450924000968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450924000968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T21:29:10Z","timestamp":1739654950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450924000968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0003450924000968"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2024.06.003","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanosuspensions: Enhancing drug bioavailability through nanonization","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2024.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}